Skip to main content

Peer Review reports

From: Tamoxifen in Duchenne muscular dystrophy (TAMDMD): study protocol for a multicenter, randomized, placebo-controlled, double-blind phase 3 trial

Original Submission
17 May 2019 Submitted Original manuscript
18 Aug 2019 Reviewed Reviewer Report - Dietrich Haubenberger
5 Sep 2019 Author responded Author comments - Sara Nagy
Resubmission - Version 2
5 Sep 2019 Submitted Manuscript version 2
Publishing
21 Sep 2019 Editorially accepted
21 Nov 2019 Article published 10.1186/s13063-019-3740-6

You can find further information about peer review here.

Back to article page